(Q34060785)

30 July 2017

1 reference

title

Neurotensin: peptide for the next millennium (English)

1 reference

30 July 2017

Tyler-McMahon BM

1 reference

30 July 2017

Boules M

series ordinal

1 reference

30 July 2017

Richelson E

series ordinal

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

issue

1-3

1 reference

30 July 2017

page(s)

125-136

1 reference

Neuroimmune mechanisms of intestinal responses to stress. Role of corticotropin-releasing factor and neurotensin.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Modification of pentobarbital-induced sedation by natural and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The neurobiology of neurotensin: focus on neurotensin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin: Antinocisponsive action in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Does neurotensin mediate the effects of antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin receptors: binding properties, transduction pathways, and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin and neurotensin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Mechanisms of regulation of neurotensin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Specific binding of tritiated neurotensin to rat brain membranes: characterization and regional distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

[3H]neurotensin(8-13) binds in human brain to the same sites as does [3H]neurotensin but with higher affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Structure and functional expression of the cloned rat neurotensin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Identification of a polymorphism in the human neurotensin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Molecular cloning of a levocabastine-sensitive neurotensin binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin(8-13): comparison of novel analogs for stimulation of cyclic GMP formation in neuroblastoma clone N1E-115 and receptor binding to human brain and intact N1E-115 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

CNS drug design based on principles of blood-brain barrier transport

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Pharmacokinetics of novel hexapeptides with neurotensin activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Differential neurobehavioral effects of neurotensin and structural analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KC1 versus electrical depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

In vivo studies with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Interactions of neurotensin with brain dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin receptors are located on dopamine-containing neurones in rat midbrain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin blocks certain amphetamine-induced behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Comparative Antipsychotic Profiles of Neurotensin and a Related Systemically Active Peptide Agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Atypical neuroleptic-like behavioral effects of neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin: central nervous system effects of a hypothalamic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, β-endorphin and bombesin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The effects of neuropeptides on discrete-trial conditioned avoidance responding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

[3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Reduced CSF neurotensin concentration in drug-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The effect of thyroid hormones in vitro and in vivo on hypothalamic neurotensin release and content

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Increased glucose production following neurotensin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

The effects of neurotensin on anterior pituitary hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Highly potent neurotensin analog that causes hypothermia and antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

SR142948A is a potent antagonist of the cardiovascular effects of neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

Control of anterior pituitary hormone secretion by neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900183-X

7 January 2021

10.1016/S0167-0115(00)00183-X

Identifiers

DOI

1 reference

30 July 2017

1 reference